Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Samuel L. Cytryn"'
Autor:
Samuel L. Cytryn, Yelena Y. Janjigian
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:423-429
HER2 is overexpressed in approximately 20% of esophagogastric cancer (EGC) cases. The addition of the anti-HER2 antibody, trastuzumab, to chemotherapy in 2010 was the first targeted treatment to demonstrate an improvement in survival. The aggressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c297f4d03c6d47c3bbdd0caa0c72c1f
https://doi.org/10.6004/jnccn.2023.7010
https://doi.org/10.6004/jnccn.2023.7010
